focus -WSS

focus

author：focus 2025-08-26 10:52:59 - browse：16

ASH19 CAR-T — Victor Segura Ibarra and Rita Serda, Ph.D., NCI, NIH

The Food and Drug Administration on Wednesday approved a futuristic new approach to treating cancer, clearing a Novartis therapy that has produced unprecedented results in patients with a rare and deadly cancer. The price tag: $475,000 for a course of treatment.

That sounds staggering to many patients — but it’s far less than analysts expected.

The therapy, called a CAR-T, is made by harvesting patients’ white blood cells and rewiring them to home in on tumors. Novartis’s product is the first CAR-T therapy to come before the FDA, leading a pack of novel treatments that promise to change the standard of care for certain aggressive blood cancers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： As pharma fights Medicare drug negotiation, hospitals, docs silent

WSS

Medicare explains how it will choose drugs for negotiation

Complete sequence of Y chromosome published for first time

Lab trade group sues FDA to halt regulation of lab

Appeals court upholds limits to abortion pill

FDA panel gives mixed vote on blood pressure devices

FDA panel gives mixed vote on blood pressure devices

focus

focus

knowledge

Medical leaders decry Supreme Court decision on affirmative action

Lab trade group sues FDA to halt regulation of lab

The cancer drug shortage isn’t new — and neither are the solutions

What will save rural psychiatry services? Higher Medicaid payments

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Radiation, mainstay of cancer treatment, begins a fade

Medicare proposal to cover medical devices draws a mixed reaction

Appeals court upholds limits to abortion pill

As demand for Covid shots wanes, Moderna seeks its next success

Average age of first period drops to 11.9 years, study shows

entertainment

Insmed lung disease drug hits target in key Phase 3 trial

Akili, maker of video game for ADHD, to be acquired for 34 million

NYU Langone launches private ChatGPT for its health care data

Heat waves linked to early deliveries, preterm births in new study

Childbirth

NYU Langone launches private ChatGPT for its health care data

focus

entertainment

focus

entertainment